Anlon Healthcare IPO
Anlon Healthcare IPO is listed on BSE and NSE, priced at ₹86–₹91 per share. The stock debuted at ₹92, delivering a listing gain of 1.1%. The IPO had a lot size of ₹164 shares and a minimum investment of ₹14,924.
Anlon Healthcare Limited IPO
- IPO Dates
- Aug 26, 2025 – Aug 29, 2025
- Price band
- ₹86-91 per equity share
- Minimum Investment
- ₹14,924
- Issue size
- ₹121.03 Cr
- Lot size
- 164
- Allotment Date
- Sep 1, 2025
- Listing
- Sep 3, 2025
- Listing At
- BSE, NSE
IPO timeline
-
Aug 26, 2025
Open Date
Completed
-
Aug 29, 2025
Close Date
Completed
-
Sep 1, 2025
Allotment Date
Completed
-
Sep 3, 2025
Listing Date
Completed
Price Summary
- Last closing
- 14.29 (-84.3%)
- 52 week high
- 17.27
- 52 week low
- 9.08
- Last update
Anlon Healthcare IPO Subscription Details
View Subscription DetailsAnlon Healthcare IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.
Last updated:Anlon Healthcare IPO Essentials
Anlon Healthcare IPO Details
Anlon Healthcare IPO is priced at ₹86-91 per share with a total issue size of 121.03 crore. The IPO has a lot size of 164 shares and is listed on BSE and NSE.
- Issue price
- ₹86-91 per equity share
- Lot size
- 164 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 1,33,00,000 shares(aggregating up to ₹121.03 Cr)
- Total issue size
- 1,33,00,000 shares
(aggregating up to ₹121.03 crore) - Fresh issue
- 1,33,00,000 shares
(aggregating up to ₹121.03 crore) - Listing at
- BSE, NSE
- List price
- 92.0(NSE)
- Listing date
- Registrar
- Kfin Technologies Ltd
- Lead manager
-
Interactive Financial Services Ltd
Market Lot Size
Investors can bid for a minimum of 164 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 164 | ₹14,924 |
| Retail(max) | 13 | 2,132 | ₹1,94,012 |
| sHNI(min) | 14 | 2,296 | ₹2,08,936 |
| sHNI(max) | 67 | 10,988 | ₹9,99,908 |
| sHNI(min) | 68 | 11,152 | ₹10,14,832 |
Anlon Healthcare IPO Reservation
Anlon Healthcare IPO reservation details show category-wise allocation of shares. Out of the total 1,33,00,000 shares, approximately 75% are reserved for QIB, 15% for NII, and 10% for retail investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | NA (NA%) | |
| QIB Shares Offered | 99,75,000 (75%) | |
| NII (HNI) Shares Offered | 19,95,000 (15%) | |
| bHNI > ₹10L | 13,30,000 (10%) | 579 |
| sHNI < ₹10L | 6,65,000 (5%) | 289 |
| Retail Shares Offered | 13,30,000 (10%) | 8109 |
| Total Shares Offered | 1,33,00,000 (100%) |
Anlon Healthcare IPO Analytics
Anlon Healthcare IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Anlon Healthcare IPO Subscription Status
Anlon Healthcare IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO is currently subscribed 7.12x, indicating strong demand across investor categories.
| As on | QIB |
NII
bHNI
sHNI
|
Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 99,75,000 |
19,95,000
13,30,000
6,65,000
|
13,30,000 | 1,33,00,000 |
|
Day 1
26-08-25 05:00 PM
|
0.91 x |
0.71x
0.48x
1.17x
|
8.99 x | 1.69 x |
|
Day 2
28-08-25 05:00 PM
|
1.01 x |
2.09x
1.38x
3.51x
|
22.32 x | 3.30 x |
|
Day 3
28-08-25 05:00 PM
|
1.07 x |
10.60x
7.56x
16.66x
|
47.04 x | 7.10 x |
|
Total No. of Applications
|
bHNI | sHNI | Retail |
|---|---|---|---|
| 339940 (Approx) | 1.52x | 16.01x | 41.24x |
Anlon Healthcare Valuations
Earnings
- EPS Pre IPO
- ₹5.15/-
- EPS Post IPO
- ₹3.86/-
- P/E Pre IPO
- 17.67
- P/E Post IPO
- 23.57
Returns
- ROE
- 40.45%
- ROCE
- 21.93%
- RoNW
- 25.51%
- PAT Margin
- 17.06%
Fundamentals
- Debt / Equity
- 0.73
- Price / Book
- 4.51
Anlon Healthcare Financials( In Crs.)
| 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|
| Assets | 181.30 | 128.00 | 111.55 |
| Revenue | 120.46 | 66.69 | 113.12 |
| Profit After Tax | 20.52 | 9.66 | 5.82 |
| Net Worth | 80.42 | 21.03 | 7.37 |
| Reserves & Surplus | 40.57 | 5.03 | -4.63 |
| Total Borrowing | 58.35 | 74.56 | 66.39 |
Anlon Healthcare Company & Offer Insights
About Anlon Healthcare
Anlon Healthcare Limited was incorporated in 2013. It is a chemical manufacturing firm involved in the production of Pharma Intermediates and active pharmaceutical ingredients (APIs).
The firm produces high-purity pharmaceutical intermediates (for API synthesis) and active pharmaceutical ingredients (utilized in formulations for pharmaceuticals, nutraceuticals, personal care, and animal health products).The firm deals in pharma intermediates, APIs for drugs, nutraceuticals, personal care, and veterinary products, all of which are produced to Indian and international pharmacopeia standards such as IP, BP, EP, JP, and USP.Besides producing Pharma Intermediates and APIs to international specifications, the firm now provides contract manufacturing of complex chemicals beyond purity levels and lowering impurities to suit particular customers' requirements.
The firm has been approved by ANVISA, NMPA, and PMDA for loxoprofen sodium dihydrate and loxoprofen acid APIs in terms of Drug Master File (DMF). The firm has submitted 21 DMFs to worldwide authorities and is submitting for Ketoprofen and Dexketoprofen Trometamol approvals.65 commercial products, 28 pilot-scale products, and 49 lab-scale products are part of the firm's portfolio.
The firm maintains product quality through thorough testing, analysis, and process optimization. Backed by four laboratories, the 34-strong team, which comprises 24 science graduates, guarantees that products meet customer and industry requirements.
Anlon Healthcare Promoter(s)
Punitkumar R. rasadia, Meet Atulkumar Vachhani, Mamata punitkumar Rasadia are the company's promoters of Anlon Healthcare.
Anlon Healthcare IPO Issue Objectives
- •
- Funding capital expenditure requirements for Proposed Expansion
- •
- Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company
- •
- Funding the working capital requirements of the Company
- •
- General corporate purposes
Anlon Healthcare IPO - Strengths and Risks
Anlon Healthcare IPO strengths and risks highlight key business factors, financial position, and market sentiment that may impact investor interest.
Strengths
Risks
Contact Information
Contact Details
Anlon Healthcare
+91 281 2562538
101/102, Silvercoin Complex, Opp.Crystal Mall,Kalawad Road Rajkot, Gujarat, 360005
Registrar Contact Details
Kfin Technologies Limited
04067162222, 04079611000
Frequently Asked Questions
Click any question to reveal the answer
Anlon Healthcare IPO is a book-built IPO worth ₹121.03 crore. The price band is ₹86–₹91 per share. The IPO opens on Aug 26, 2025 and closes on Aug 29, 2025. It will be listed on BSE and NSE. Kfin Technologies Ltd is the registrar.
The price band of Anlon Healthcare IPO is ₹86 to ₹91 per share.
The lot size of Anlon Healthcare IPO is 164 shares.
The minimum investment for Anlon Healthcare IPO is approximately ₹14,924 based on the upper price band .
Anlon Healthcare IPO opens on Aug 26, 2025 and closes on Aug 29, 2025.
The allotment date of Anlon Healthcare IPO is Sep 1, 2025.
Anlon Healthcare IPO is expected to be listed on Sep 3, 2025, on BSE and NSE .
Anlon Healthcare IPO listed on Sep 3, 2025. It was issued at ₹92.0(NSE) and is currently around ₹14.29 as on 27-May-2026 3:30 PM, which is approximately -84.3% versus issue price. The 52-week high is ₹17.27.
Based on listing and post-listing performance, Anlon Healthcare IPO delivered around -84.3% over issue price. Whether it was worth applying depends on your risk profile, allocation, and holding horizon.
To buy Anlon Healthcare IPO shares after listing, log in to your broker app (such as Zerodha, Angel One, Groww, Upstox, ICICI Direct), search the stock symbol, place a delivery/CNC order, and confirm quantity and price.
Anlon Healthcare IPO valuation snapshot: P/E 23.57, EPS ₹3.86/-, P/B 4.51, RoNW 25.51%, and market cap N/A.
To apply for Anlon Healthcare IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Anlon Healthcare IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Anlon Healthcare IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Anlon Healthcare IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Anlon Healthcare IPO allotment status on IPO Ji for quick and easy access.